Loading company…
Nektar's PEGylation reagent business manufactures activated polyethylene glycol derivatives and related products.
Based in the US, the business develops and manufactures activated polyethylene glycol derivatives and related products. It includes a commercial-scale specialized manufacturing facility in Huntsville, Alabama, and supply chains for PEGylated therapeutics. In December 2024, Ampersand Capital Partners acquired the business from Nektar for USD 90 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Nektar's PEGylation reagent manufacturing business? This is my company